FDA daily

FDA daily for Thursday, November 19, 2026

In this issue: 37 shortage updates, 7 approvals, 25 device decisions, 202 label changes and a new batch of complete response letters. 3 items touch categories MedGrid carries, and they come first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug shortages

FDA date:

FDA updated 37 shortage entries on Wed, Nov 18: 37 status updates.

Browse drug shortages in FDA data →

Drug and biologic approvals

FDA date:

On Thu, Nov 12 FDA approved 3 new applications (1 brand or biologic, 2 generic) and 4 supplements to existing ones.

Browse drug and biologic approvals in FDA data →

Device clearances and approvals

FDA date:

FDA decided 17 510(k)s and 8 PMA decisions on Thu, Nov 5.

Browse device clearances and approvals in FDA data →

Label updates

FDA date:

202 drug labels took effect on Thu, Nov 5; 1 of the 25 read for this issue is for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.

  • Invisible Sunscreen SPF 40

    HOMOSALATE, OCTISALATE, AVOBENZONE, OCTOCRYLENE · PARTICLE AESTHETIC SCIENCE LTD · TOPICAL

    Sunscreen & SPFHUMAN OTC DRUG
  • Clopidogrel Bisulfate

    CLOPIDOGREL BISULFATE · PD-Rx Pharmaceuticals, Inc. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Oxycodone and Acetaminophen

    OXYCODONE AND ACETAMINOPHEN · American Health Packaging · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • temazepam

    TEMAZEPAM · Bryant Ranch Prepack · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • CYCLOSPORINE

    CYCLOSPORINE · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Warfarin Sodium

    WARFARIN SODIUM · PD-Rx Pharmaceuticals, Inc. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
Browse label updates in FDA data →

Complete response letters

FDA date:

FDA published a new batch of complete response letters, the letters that explain why an application was not approved as submitted. 2026 now has 39 letters; the newest are below.

  • Summit Therapeutics Inc. · BLA 761524

    yy U.S. FOOD & DRUG ADMINISTRATION BLA 761524 COMPLETE RESPONSE Summit Therapeutics Inc. Attention: Darshan Gandhi Associate Director, Regulatory Affairs 601 Brickell Key Drive, Suite 1000 Miami, FL…

    COMPLETE RESPONSEUnapproved
  • Cristcot HCA LLC · NDA 220054

    YN U.S. FOOD & DRUG ADMINISTRATION NDA 220054 COMPLETE RESPONSE Cristcot HCA LLC Attention: Jennifer Davagian President 9 Damonmill Square Suite 4A Concord, MA 01742 Dear Jennifer Davagian: Please re…

    COMPLETE RESPONSEUnapprovedCenter for Drug Evaluation and Research
  • SEIKAGAKU Corporation · BLA 761393

    ADMINISTRATION ¢ YN U.S. FOOD & DRUG BLA 761393 COMPLETE RESPONSE SEIKAGAKU Corporation c/o PAREXEL International 2520 Meridian Parkway, Suite 100 Durham, NC 27713 Attention: Katherine Fertal US Agen…

    COMPLETE RESPONSEUnapproved
  • Xspray Pharma AB · NDA 216195

    g U.S. FOOD & DRUG ADMINISTRATION a NDA 216195 COMPLETE RESPONSE Xspray Pharma AB c/o Lachman Consultant Services, Inc. Attention: Jennifer Leaming, MSRA, RAC US Agent; Principal Consultant 1600 Stew…

    COMPLETE RESPONSEUnapproved
  • SamChunDang Pharm. Co., Ltd. · BLA 761494

    i Lk YN U.S. FOOD & DRUG ADMINISTRATION BLA 761494 COMPLETE RESPONSE SamChunDang Pharm. Co., Ltd. c/o PPD Development L.P. Attention: Prudence Ciardullo RA Senior Manager 3900 Parkway Plaza Morrisvil…

    COMPLETE RESPONSEUnapproved
  • ITM Solucin GmbH · NDA 218705

    g U.S. FOOD & DRUG Naty ADMINISTRATION NDA 218705 COMPLETE RESPONSE ITM Solucin GmbH c/o Lumara Bio USA Inc. Attention: Tinya Sow, MHA US Agent, Director - US, Regulatory Lead 5 Vaughn Drive, Suite 3…

    COMPLETE RESPONSEUnapproved
  • Fresenius Kabi USA, LLC · NDA 220381/Original 2,NDA 220381

    yy U.S. FOOD & DRUG ADMINISTRATION NDA 220381/Original 2 COMPLETE RESPONSE Fresenius Kabi USA, LLC Attention: Winnie Chen Regulatory Technical Manager Three Corporate Drive Lake Zurich, IL 60047 Dear…

    COMPLETE RESPONSEApprovedCenter for Drug Evaluation and Research
  • Apiject Systems Corp. · NDA 219107

    PN U.S. FOOD & DRUG ADMINISTRATION NDA 219107 COMPLETE RESPONSE Apiject Systems Corp. Attention: Ashley Dynan Senior Director of Regulatory Affairs 2 High Ridge Park Stamford, CT 06905 Dear Ashley Dy…

    COMPLETE RESPONSEUnapproved
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd. · BLA 761308

    yy U.S. FOOD & DRUG ADMINISTRATION BLA 761308 COMPLETE RESPONSE Jiangsu Hengrui Pharmaceuticals Co., Ltd. c/o Hengrui U.S.A., Inc. Attention: Brahmaiah Kommanaboyina US Agent Head of U.S. Regulatory…

    COMPLETE RESPONSEUnapproved
  • Elevar Therapeutics Inc. · NDA 216586

    i Lk YN U.S. FOOD & DRUG ADMINISTRATION NDA 216586 COMPLETE RESPONSE Elevar Therapeutics Inc. ATTENTION: Young-Sil (Anna) Yim Executive Director, Regulatory Affairs: 1 Bridge Plaza North, Suite 850 F…

    COMPLETE RESPONSEUnapproved
Browse complete response letters in FDA data →

FDA did not answer for Food and supplement recalls, Drug recalls, Device recalls while this issue was written; those sections will fill in on a later visit.

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.